Pharmagest Interactive SA
F:PHF

Watchlist Manager
Pharmagest Interactive SA Logo
Pharmagest Interactive SA
F:PHF
Watchlist
Price: 44.1 EUR 2.2% Market Closed
Market Cap: 663m EUR
Have any thoughts about
Pharmagest Interactive SA?
Write Note

Pharmagest Interactive SA
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharmagest Interactive SA
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Pharmagest Interactive SA
F:PHF
Interest Income Expense
€3.2m
CAGR 3-Years
53%
CAGR 5-Years
26%
CAGR 10-Years
11%
Cegedim SA
PAR:CGM
Interest Income Expense
-€10.3m
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
14%
Equasens SA
PAR:EQS
Interest Income Expense
€3.2m
CAGR 3-Years
53%
CAGR 5-Years
26%
CAGR 10-Years
11%
Median Technologies SA
PAR:ALMDT
Interest Income Expense
-€182k
CAGR 3-Years
68%
CAGR 5-Years
-14%
CAGR 10-Years
-25%
No Stocks Found

Pharmagest Interactive SA
Glance View

Market Cap
662.9m EUR
Industry
Health Care

Pharmagest Interactive SA engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. The company operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.

PHF Intrinsic Value
71.3 EUR
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Pharmagest Interactive SA's Interest Income Expense?
Interest Income Expense
3.2m EUR

Based on the financial report for Dec 31, 2023, Pharmagest Interactive SA's Interest Income Expense amounts to 3.2m EUR.

What is Pharmagest Interactive SA's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
11%

Over the last year, the Interest Income Expense growth was 256%. The average annual Interest Income Expense growth rates for Pharmagest Interactive SA have been 53% over the past three years , 26% over the past five years , and 11% over the past ten years .

Back to Top